ePharmacy Market Updates by 2031
E-prescription is the electronic prescribing technology that permits healthcare professionals to go paperless by sending prescriptions in digital format instead of handwritten prescriptions. Doctors now prefer e-prescriptions to enable patients to get easy access to medicine with the help of e-prescriptions. The significant advantage of e-prescription is that one can easily upload their e-prescription on the e-pharmacy website and order medicine online without any obstacle. Therefore, due to the rising implementation of e-prescriptions, uploading the prescription online has become easy and less time-consuming..
MARKET SCOPE
The "Global EPharmacy Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the ePharmacy market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading ePharmacy market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on drug type, the global ePharmacy market is segmented into over the counter drugs, prescription drugs.
- On the basis of product, the market is segmented into skin care, dental, cold and flu, others.
MARKET DYNAMICS
Drivers:
- Rise in the number of internet consumers.
- Growing access to web-based and online services.
- Rising implementation of e-prescriptions in hospitals and other healthcare services
Restraints:
- The increasing number of illegal online pharmacies, and low penetration in rural areas in developing countries is the major restraining factor for this market.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The ePharmacy market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the ePharmacy market in these regions.
IMPACT OF COVID-19 ON EPHARMACY MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The ePharmacy market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the ePharmacy market in these regions.
IMPACT OF COVID-19 ON EPHARMACY MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the ePharmacy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from ePharmacy market are anticipated to lucrative growth opportunities in the future with the rising demand for ePharmacy in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the ePharmacy market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- CVS Health Corporation
- DocMorris
- Giant Eagle Inc.
- Rowlands Pharmacy
- The Kroger Corporation
- Walmart Stores Inc.
- Walgreen Co.
- Express Scripts Holding Company
- VS Health
- OptumRx, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 EPharmacy Market - By Drug Type
1.3.2 EPharmacy Market - By Product
1.3.3 EPharmacy Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. EPHARMACY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. EPHARMACY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. EPHARMACY MARKET - GLOBAL MARKET ANALYSIS
6.1. EPHARMACY - GLOBAL MARKET OVERVIEW
6.2. EPHARMACY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. EPHARMACY MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. OVER THE COUNTER DRUGS
7.3.1. Overview
7.3.2. Over the Counter Drugs Market Forecast and Analysis
7.4. PRESCRIPTION DRUGS
7.4.1. Overview
7.4.2. Prescription Drugs Market Forecast and Analysis
8. EPHARMACY MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
8.1. OVERVIEW
8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
8.3. SKIN CARE
8.3.1. Overview
8.3.2. Skin Care Market Forecast and Analysis
8.4. DENTAL
8.4.1. Overview
8.4.2. Dental Market Forecast and Analysis
8.5. COLD AND FLU
8.5.1. Overview
8.5.2. Cold and Flu Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. EPHARMACY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America EPharmacy Market Overview
9.1.2 North America EPharmacy Market Forecasts and Analysis
9.1.3 North America EPharmacy Market Forecasts and Analysis - By Drug Type
9.1.4 North America EPharmacy Market Forecasts and Analysis - By Product
9.1.5 North America EPharmacy Market Forecasts and Analysis - By Countries
9.1.5.1 United States EPharmacy Market
9.1.5.1.1 United States EPharmacy Market by Drug Type
9.1.5.1.2 United States EPharmacy Market by Product
9.1.5.2 Canada EPharmacy Market
9.1.5.2.1 Canada EPharmacy Market by Drug Type
9.1.5.2.2 Canada EPharmacy Market by Product
9.1.5.3 Mexico EPharmacy Market
9.1.5.3.1 Mexico EPharmacy Market by Drug Type
9.1.5.3.2 Mexico EPharmacy Market by Product
9.2. EUROPE
9.2.1 Europe EPharmacy Market Overview
9.2.2 Europe EPharmacy Market Forecasts and Analysis
9.2.3 Europe EPharmacy Market Forecasts and Analysis - By Drug Type
9.2.4 Europe EPharmacy Market Forecasts and Analysis - By Product
9.2.5 Europe EPharmacy Market Forecasts and Analysis - By Countries
9.2.5.1 Germany EPharmacy Market
9.2.5.1.1 Germany EPharmacy Market by Drug Type
9.2.5.1.2 Germany EPharmacy Market by Product
9.2.5.2 France EPharmacy Market
9.2.5.2.1 France EPharmacy Market by Drug Type
9.2.5.2.2 France EPharmacy Market by Product
9.2.5.3 Italy EPharmacy Market
9.2.5.3.1 Italy EPharmacy Market by Drug Type
9.2.5.3.2 Italy EPharmacy Market by Product
9.2.5.4 Spain EPharmacy Market
9.2.5.4.1 Spain EPharmacy Market by Drug Type
9.2.5.4.2 Spain EPharmacy Market by Product
9.2.5.5 United Kingdom EPharmacy Market
9.2.5.5.1 United Kingdom EPharmacy Market by Drug Type
9.2.5.5.2 United Kingdom EPharmacy Market by Product
9.2.5.6 Rest of Europe EPharmacy Market
9.2.5.6.1 Rest of Europe EPharmacy Market by Drug Type
9.2.5.6.2 Rest of Europe EPharmacy Market by Product
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific EPharmacy Market Overview
9.3.2 Asia-Pacific EPharmacy Market Forecasts and Analysis
9.3.3 Asia-Pacific EPharmacy Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific EPharmacy Market Forecasts and Analysis - By Product
9.3.5 Asia-Pacific EPharmacy Market Forecasts and Analysis - By Countries
9.3.5.1 Australia EPharmacy Market
9.3.5.1.1 Australia EPharmacy Market by Drug Type
9.3.5.1.2 Australia EPharmacy Market by Product
9.3.5.2 China EPharmacy Market
9.3.5.2.1 China EPharmacy Market by Drug Type
9.3.5.2.2 China EPharmacy Market by Product
9.3.5.3 India EPharmacy Market
9.3.5.3.1 India EPharmacy Market by Drug Type
9.3.5.3.2 India EPharmacy Market by Product
9.3.5.4 Japan EPharmacy Market
9.3.5.4.1 Japan EPharmacy Market by Drug Type
9.3.5.4.2 Japan EPharmacy Market by Product
9.3.5.5 South Korea EPharmacy Market
9.3.5.5.1 South Korea EPharmacy Market by Drug Type
9.3.5.5.2 South Korea EPharmacy Market by Product
9.3.5.6 Rest of Asia-Pacific EPharmacy Market
9.3.5.6.1 Rest of Asia-Pacific EPharmacy Market by Drug Type
9.3.5.6.2 Rest of Asia-Pacific EPharmacy Market by Product
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa EPharmacy Market Overview
9.4.2 Middle East and Africa EPharmacy Market Forecasts and Analysis
9.4.3 Middle East and Africa EPharmacy Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa EPharmacy Market Forecasts and Analysis - By Product
9.4.5 Middle East and Africa EPharmacy Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa EPharmacy Market
9.4.5.1.1 South Africa EPharmacy Market by Drug Type
9.4.5.1.2 South Africa EPharmacy Market by Product
9.4.5.2 Saudi Arabia EPharmacy Market
9.4.5.2.1 Saudi Arabia EPharmacy Market by Drug Type
9.4.5.2.2 Saudi Arabia EPharmacy Market by Product
9.4.5.3 U.A.E EPharmacy Market
9.4.5.3.1 U.A.E EPharmacy Market by Drug Type
9.4.5.3.2 U.A.E EPharmacy Market by Product
9.4.5.4 Rest of Middle East and Africa EPharmacy Market
9.4.5.4.1 Rest of Middle East and Africa EPharmacy Market by Drug Type
9.4.5.4.2 Rest of Middle East and Africa EPharmacy Market by Product
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America EPharmacy Market Overview
9.5.2 South and Central America EPharmacy Market Forecasts and Analysis
9.5.3 South and Central America EPharmacy Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America EPharmacy Market Forecasts and Analysis - By Product
9.5.5 South and Central America EPharmacy Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil EPharmacy Market
9.5.5.1.1 Brazil EPharmacy Market by Drug Type
9.5.5.1.2 Brazil EPharmacy Market by Product
9.5.5.2 Argentina EPharmacy Market
9.5.5.2.1 Argentina EPharmacy Market by Drug Type
9.5.5.2.2 Argentina EPharmacy Market by Product
9.5.5.3 Rest of South and Central America EPharmacy Market
9.5.5.3.1 Rest of South and Central America EPharmacy Market by Drug Type
9.5.5.3.2 Rest of South and Central America EPharmacy Market by Product
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL EPHARMACY MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. EPHARMACY MARKET, KEY COMPANY PROFILES
12.1. CVS HEALTH CORPORATION
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. DOCMORRIS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GIANT EAGLE INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ROWLANDS PHARMACY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. WALMART STORES INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. WALGREEN CO.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. EXPRESS SCRIPTS HOLDING COMPANY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. VS HEALTH
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. OPTUMRX, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. CVS Health Corporation
2. DocMorris
3. Giant Eagle Inc.
4. Rowlands Pharmacy
5. The Kroger Corporation
6. Walmart Stores Inc.
7. Walgreen Co.
8. Express Scripts Holding Company
9. VS Health
10. OptumRx, Inc.
11. Domzdrowia.pl
12. MediSave
13. Rite Aid Corp
14. Lloyds Pharmacy
15. Canada Drugs
16. Planter
17. Medicate
18. Express Scripts Holding Company
19. Secure Medical Inc.
20. Sani Care
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For